# Established Status Epilepticus Treatment Trial

> **NCT01960075** · PHASE3 · COMPLETED · sponsor: **University of Virginia** · enrollment: 478 (actual)

## Conditions studied

- Benzodiazepine Refractory Status Epilepticus

## Interventions

- **DRUG:** Fosphenytoin
- **DRUG:** Levetiracetam
- **DRUG:** Valproic acid

## Key facts

- **NCT ID:** NCT01960075
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-02
- **Final completion:** 2019-05
- **Target enrollment:** 478 (ACTUAL)
- **Last updated:** 2021-06-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960075, "Established Status Epilepticus Treatment Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01960075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*